XP vs NMR
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 22, 2026
XP
NMR
Investment Advisor Scores
NMR
AI Analyst Insights
Detailed Metrics Comparison
| Metric | XP | NMR | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 8.5034 | 15.3846 | XP |
| PEG Ratio | 0 | 0.8146 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 10.6% | 31.2% | NMR |
| Earnings Growth | 8.6% | 42.0% | NMR |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 32.9/100 | 47.7/100 | NMR |
| Profit Margin | 28.5% | 17.3% | XP |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | HOLD | NMR |
Relative Price Performance (Last 90 Days)
Current Technical Phase
XP
MarkupPrice above SMA50, rising 50-day trend (24.3% over 20 days), RSI 62
NMR
MarkdownPrice below a falling SMA50 (slope -0.8%), weak momentum, RSI 28
Fundamentals Snapshot
| Metric | XP | NMR |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 2.3 | 12.1 |
| Trailing P/E | 15.9 | 10.7 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.3% |
| Gross Margin | 0.7% | 0.8% |
| Operating Margin | 0.3% | 0.3% |
| EPS | 1.91 | 0.86 |
| Dividend Yield | 0.01% | 0.04% |